Company intelligence / Profile preview

Pictor

Carlsbad, California, United Statespictorlabs.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Pictor offers a high-throughput multiplex proteomics solution capable of delivering results in under one minute for 96 samples. The system supports up to 50 analytes per test with customizable panels for both human and animal health applications. The company emphasizes affordability, scalability, rapid turnaround time, and flexibility across multiple sample types. Its U.S. headquarters was established in Carlsbad, California in 2025 to support global expansion of its diagnostic capabilities. No direct clinical trial results are reported as it provides enabling technology rather than therapeutics.

Therapeutic areas: Infectious Diseases
Modalities: Multiplex proteomics platform
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Pictor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pictor.

Explore the full profile